内部人交易雷达

美国 · SEC Form 4 · 快照日期： 2026-10-19 · 构建时间： 2026-10-19 · English

← 美国市场 · 覆盖记录

美国 · SEC FORM 4

Fulcrum Therapeutics, Inc.

FULC · Nasdaq · CIK 0001680581 · Healthcare · Biotechnology

内部人信号

51.6 / 100

1 位买方 · 6 条买入交易行 · $1.5M 买入总额

为什么有这个信号？

买方广度较低
买入规模中等
角色中等
近期性较低
确信度较强
评分构成

每条进度条表示其对当前分数的贡献；权重和公式保持不变。

Cluster+7.0 / 35
买入规模+19.0 / 25
角色+14.0 / 20
近期性+2.1 / 10
确信度+9.6 / 10

哪些因素限制了当前分数？

  • ⚠ Cluster breadth is moderate · 1 insider(s), not 4+
  • ⚠ 角色得分低 · 买入者中职位最高的是：TenPercentOwner（CEO、董事长和持股 10% 以上的股东得分最低）
  • ⚠ Purchase activity is becoming less recent

Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.

US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后，不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。

买方广度与集中度

合资格买方1
买入集中度100%最大买方： TANG CAPITAL MANAGEMENT LLC; TANG KEVIN · $1.5M
聚集买入 · 15天1 insider峰值活动： 2026-07-13–2026-07-17

Roles in the peak window: TenPercentOwner. Concentration uses priced qualifying P lines only and does not change the saved score.

内部人活动时间轴

申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。

AprMayJunJulAugSepOct
TANG CAPITAL MANAGEMENT LLC; TANG KEVINTenPercentOwner
●●●●●
Ezekowitz AlanDirector
▼
● 买入▼ 卖出○ 其他

—

信号历史

51.6 / 100

最新留档分数

→ +0.0 pts相对上一个留档快照
  1. 51.9
  2. 51.8
  3. 51.7
  4. 51.6
  5. 51.6

Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.

近期 Form 4 活动

6买入
9卖出
0其他 Form 4 交易行
9SEC 申报 · 365天
买入6 qualifying P line(s) · 180 days
卖出1 sale line(s) · 仅供背景
其他0 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

市场背景

市场背景补充近期价格表现与风险信息，不影响内部人信号。

价格表现

1M
-0.8%
3M
+6.5%
6M
-50.1%
12M
-60.9%

波动率与流动性

波动率
85.6%
Beta
—
平均每日成交额
USD 5.8M

估值

市值
USD 287.6M
P/E
—

基本面

利润率
—
ROE
-21.5%
细分行业
Biotechnology

市场数据

价格数据截至：2026-10-11 · 价格来源：OpenBB/yfinance; 成交量来自 本机价格缓存 (yfinance) · 来自 SEC 申报文件：市值, ROE · 财年截止日：2025-12-31 · 市值 = 申报文件封面所列的已发行股数 × 最新收盘价。股数日期：2026-07-23 · Status: PASS

空头余额

空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。

空头股数
7,110,810
上期报告
7,194,912
日均成交量
1,587,423
回补天数
4.5

FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。

历史股票买入

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting owner类型证券股数平均价格估算金额来源
2026-07-17TANG CAPITAL MANAGEMENT LLC; TANG KEVIN买入 (P)Common Stock50,945USD 3.52USD 179,326SEC 申报 ↗
2026-07-16TANG CAPITAL MANAGEMENT LLC; TANG KEVIN买入 (P)Common Stock116,671USD 3.56USD 415,349SEC 申报 ↗
2026-07-15TANG CAPITAL MANAGEMENT LLC; TANG KEVIN买入 (P)Common Stock107,377USD 3.56USD 382,262SEC 申报 ↗
2026-07-14TANG CAPITAL MANAGEMENT LLC; TANG KEVIN买入 (P)Common Stock129,603USD 3.57USD 462,906SEC 申报 ↗
2026-07-13TANG CAPITAL MANAGEMENT LLC; TANG KEVIN买入 (P)Common Stock12,966USD 3.54USD 45,900SEC 申报 ↗
2024-03-04Sapir Alex买入 (P)Common Stock43,360USD 11.35USD 492,136SEC 申报 ↗
2023-01-20Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M.买入 (P)Common Stock1,923,076USD 13.00USD 24,999,988SEC 申报 ↗
2023-01-04Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M.买入 (P)Common Stock180,703USD 7.28USD 1,315,286SEC 申报 ↗
2022-12-27Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M.买入 (P)Common Stock4,089USD 5.99USD 24,493SEC 申报 ↗
2022-12-19Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M.买入 (P)Common Stock98,787USD 5.90USD 582,843SEC 申报 ↗
2022-12-16Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M.买入 (P)Common Stock1,341,420USD 5.42USD 7,270,496SEC 申报 ↗
2022-12-15Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M.买入 (P)Common Stock237,029USD 5.50USD 1,303,660SEC 申报 ↗
2022-12-14Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M.买入 (P)Common Stock824,600USD 5.46USD 4,502,316SEC 申报 ↗
2021-06-28Thomson Peter G.买入 (P)Common Stock2,300USD 9.00USD 20,700SEC 申报 ↗
2021-06-28Oltmans Curtis Gale买入 (P)Common Stock1,088USD 9.01USD 9,803SEC 申报 ↗

Form 4 申报证据

15 transaction lines in the latest 365-day window; 127 in local history.

日期申报人类型证券股数平均价格估算金额来源
2026-07-17TANG CAPITAL MANAGEMENT LLC; TANG KEVIN买入 (P)Common Stock50,945USD 3.52USD 179,326SEC 申报 ↗
2026-07-16TANG CAPITAL MANAGEMENT LLC; TANG KEVIN买入 (P)Common Stock116,671USD 3.56USD 415,349SEC 申报 ↗
2026-07-15TANG CAPITAL MANAGEMENT LLC; TANG KEVIN买入 (P)Common Stock107,377USD 3.56USD 382,262SEC 申报 ↗
展开近期 Form 4 证据 (12 grouped rows)
日期申报人类型证券股数平均价格估算金额来源
2026-07-17TANG CAPITAL MANAGEMENT LLC; TANG KEVIN买入 (P)Common Stock50,945USD 3.52USD 179,326SEC 申报 ↗
2026-07-16TANG CAPITAL MANAGEMENT LLC; TANG KEVIN买入 (P)Common Stock116,671USD 3.56USD 415,349SEC 申报 ↗
2026-07-15TANG CAPITAL MANAGEMENT LLC; TANG KEVIN买入 (P)Common Stock107,377USD 3.56USD 382,262SEC 申报 ↗
2026-07-14TANG CAPITAL MANAGEMENT LLC; TANG KEVIN买入 (P)Common Stock129,603USD 3.57USD 462,906SEC 申报 ↗
2026-07-13TANG CAPITAL MANAGEMENT LLC; TANG KEVIN买入 (P)Common Stock12,966USD 3.54USD 45,900SEC 申报 ↗
2026-06-26Ezekowitz Alan卖出 (S)Common Stock18,000USD 3.65USD 65,700SEC 申报 ↗
2026-02-02Gould Robert J卖出 (S)Common Stock15,000USD 10.72USD 160,800SEC 申报 ↗
2026-01-02Gould Robert J卖出 (S)Common Stock15,000USD 10.87USD 163,050SEC 申报 ↗
2026-01-02Gould Robert J卖出 (S)Common Stock15,000USD 11.87USD 178,050SEC 申报 ↗
2025-12-15Oltmans Curtis Gale卖出 (S)Common Stock3,452USD 12.92USD 44,600SEC 申报 ↗
2025-12-08Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M.卖出 (S)Common Stock4,175,139USD 13.98USD 58,377,021SEC 申报 ↗
2025-11-19Gould Robert J卖出 (S)Common Stock15,000USD 11.03USD 165,450SEC 申报 ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

快照与身份

快照日期2026-10-19
排名版本US-v1.2
数据质量PASS ELIGIBLE · —
股票代码FULC
CIK0001680581
行业Healthcare
细分行业Biotechnology Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
交易所Nasdaq

数据覆盖

本地 Form 4 历史127 transaction lines from 2020-01-23 to 2026-07-17
19 P purchase lines · 70 S sale lines · 38 other lines
SEC 公司申报打开 SEC 申报 ↗

Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.